Cargando…

Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-Analysis

BACKGROUND: Urologists are frequently confronted with questions of urinary bladder cancer (UBC) patients about what they can do to improve their prognosis. Unfortunately, it is largely unknown which lifestyle factors can influence prognosis. OBJECTIVE: To systematically review the available evidence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westhoff, Ellen, Witjes, J. Alfred, Fleshner, Neil E., Lerner, Seth P., Shariat, Shahrokh F., Steineck, Gunnar, Kampman, Ellen, Kiemeney, Lambertus A., Vrieling, Alina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798521/ https://www.ncbi.nlm.nih.gov/pubmed/29430510 http://dx.doi.org/10.3233/BLC-170147

Ejemplares similares

The UroLife study: protocol for a Dutch prospective cohort on lifestyle habits in relation to non-muscle-invasive bladder cancer prognosis and health-related quality of life
por: de Goeij, Liesbeth, et al.
Publicado: (2019)

Adherence to the WCRF/AICR Cancer Prevention Recommendations and Risk of Recurrence in Non-muscle Invasive Bladder Cancer
por: van Zutphen, Moniek, et al.
Publicado: (2022)

Limited Changes in Lifestyle Behaviours after Non-Muscle Invasive Bladder Cancer Diagnosis
por: Beeren, Ivy, et al.
Publicado: (2022)

Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer
por: Ripping, Theodora M., et al.
Publicado: (2021)

Body mass index and waist circumference in relation to risk of recurrence and progression after non‐muscle invasive bladder cancer
por: van Zutphen, Moniek, et al.
Publicado: (2023)

Cohort profile – the Renal cell cancer: Lifestyle, prognosis and quality of life (ReLife) study in the Netherlands
por: Maurits, Jake S F, et al.
Publicado: (2023)

Impact of Diet, Body Mass Index, and Physical Activity on Cancer Survival
por: Kampman, Ellen, et al.
Publicado: (2012)

Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment Response
por: Grotenhuis, Anne J., et al.
Publicado: (2016)

No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
por: Evers, Jelle, et al.
Publicado: (2020)

Smoking intensity and bladder cancer aggressiveness at diagnosis
por: Barbosa, André L. A., et al.
Publicado: (2018)

The prognostic value of family history among patients with urinary bladder cancer
por: Egbers, Lieke, et al.
Publicado: (2015)

Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer
por: Kok, Dieuwertje E. G., et al.
Publicado: (2010)

Identification of long non-coding RNAs that stimulate cell survival in bladder cancer
por: Dudek, Aleksandra M., et al.
Publicado: (2017)

Personal hair dye use and the risk of bladder cancer: a case–control study from The Netherlands
por: Ros, Martine M., et al.
Publicado: (2012)

LINC00857 expression predicts and mediates the response to platinum‐based chemotherapy in muscle‐invasive bladder cancer
por: Dudek, Aleksandra M., et al.
Publicado: (2018)

Non‐metastatic muscle‐invasive bladder cancer: the role of age in receiving treatment with curative intent
por: van Hoogstraten, Lisa M.C., et al.
Publicado: (2022)

Determinants of adherence to recommendations for cancer prevention among Lynch Syndrome mutation carriers: A qualitative exploration
por: Visser, Annemiek, et al.
Publicado: (2017)

Prognostic Relevance of Urinary Bladder Cancer Susceptibility Loci
por: Grotenhuis, Anne J., et al.
Publicado: (2014)

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer
por: D'Andrea, David, et al.
Publicado: (2019)

Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer
por: van Hoogstraten, Lisa M. C., et al.
Publicado: (2023)

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
por: van Puffelen, Jelmer H, et al.
Publicado: (2023)

The association of body composition with postoperative complications and length of hospital stay after radical or partial nephrectomy in patients with renal cell cancer: a multicenter population-based cohort study
por: Maurits, Jake S. F., et al.
Publicado: (2022)

The present and future burden of urinary bladder cancer in the world
por: Ploeg, Martine, et al.
Publicado: (2009)

A short-term intervention with selenium affects expression of genes implicated in the epithelial-to-mesenchymal transition in the prostate
por: Kok, Dieuwertje E.G., et al.
Publicado: (2017)

The global burden of urinary bladder cancer: an update
por: Richters, Anke, et al.
Publicado: (2019)

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
por: Vrieling, Alina
Publicado: (2018)

Prognostic relevance of number and bilaterality of positive surgical margins after radical prostatectomy
por: Somford, Diederik M., et al.
Publicado: (2011)

Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies?
por: Nuijens, Siberyn T., et al.
Publicado: (2023)

Follow-up in non-muscle invasive bladder cancer: facts and future
por: Witjes, J. Alfred
Publicado: (2020)

Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers
por: Soria, Francesco, et al.
Publicado: (2018)

Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis
por: Pones, Mario, et al.
Publicado: (2021)

Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer
por: Richters, Anke, et al.
Publicado: (2021)

How to optimally manage elderly bladder cancer patients?
por: Soria, Francesco, et al.
Publicado: (2016)

The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer
por: Soria, Francesco, et al.
Publicado: (2019)

Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness
por: van Roermund, Joep G. H., et al.
Publicado: (2009)

Liquid biopsies in bladder cancer—did we find the Holy Grail for biomarker analyses?
por: Rink, Michael, et al.
Publicado: (2016)

The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group.
por: Kiemeney, L. A., et al.
Publicado: (1993)

Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients
por: Michels, Charlotte T. J., et al.
Publicado: (2019)

Intravesical therapy for bladder cancer in the pandemic of Covid-19
por: Teoh, Jeremy Y. C., et al.
Publicado: (2020)

Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
por: Witjes, J Alfred, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h49841la0tth79bnlhmrcsa5aq